Cytogenetic abnormalities in 13 patients with multiple myeloma

Cancer Genetics and Cytogenetics

Volumn 86, Issue 2, 1996, Pages 162-164

  Sole F ^a   Woessner, S ^a   Acin P ^a   Perez Losada A ^a   Florensa, L ^a   Besses, C ^a   Sans Sabrafen, J ^a  

^a Hospital Central L'Alianca   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 5; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; STRUCTURE ANALYSIS;

EID: 0029966474     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00211-1     Document Type: Article

References (18)

1. Heim S, Mitelman F (1987): Cancer Cytogenetics. Alan R. Liss, New York.
2. Liang W, Hopper JE, Rowley JD (1979): Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer 44:630-644.
3. Lewis JP, MacKenzie MR (1984): Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol 2:307-317.
4. Chen K-C, Bevan PC, Matthews JG (1986): Analysis of G banded karyotypes in myeloma cells. J Clin Pathol 39:260-266.
5. Dewald GW, Kyle RA, Hicks GA, Greipp PR (1985): The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66:380-390.
6. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki Ch, Horiike S, Misawa S, Abe T, Kasima K (1994): Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283-2290.
7. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, 2nd Ed. Elsevier Science Publishing, New York.
8. Nishida K, Taniwaki M, Misawa M, Abe T (1989): Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 49:1275-1281.
9. Nishida K, Yashige H, Maekawa T, Fujii H, Taniwaki M, Noriike S, Misawa S, Inazawa J, Abe T (1989): Chromosome rearrangement, t(6;14)(p21.1;q32.3), in multiple myeloma. Br J Haematol 71:295-296.
10. Yamada K, Shionoya S, Amano M, Imamura Y (1983): Burkitt-type 8;14 translocation in a case of plasma cell leukemia. Cancer Genet Cytogenet 9:67-70.
11. Solé F, Woessner S (1992): Microwaves improve chromosome G-banding in fresh blood and bone marrow. J Clin Pathol 45:1118.
12. ISCN (1985): An International System for Human Cytogenetic Nomenclature, Harnden DG, Klinger HP (eds.); published in collaboration with Cytogenet Cell Genet (Karger, Basel, 1985); also in Birth Defects: Original Article Series, Vol. 21, No. 1 (March of Dimes Birth Defects Foundation, New York, 1985).
13. ISCN (1985): An International System for Human Cytogenetic Nomenclature, Harnden DG, Klinger HP (eds.); published in collaboration with Cytogenet Cell Genet (Karger, Basel, 1985); also in Birth Defects: Original Article Series, Vol. 21, No. 1 (March of Dimes Birth Defects Foundation, New York, 1985).
14. ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature, F Mitelman, (ed.) S Karger, Basel, 1991.
15. Rowley JD (1977): Mapping of human chromosomal regions related to neoplasia: Evidence from chromosomes 1 and 17. Proc Natl Acad Sci USA 74:5729-5733.
16. Brito-Babapulle V, Atkin NB (1981): Breakpoints in chromosome #1 abnormalities of 218 human neoplasm. Cancer Genet Cytogenet 4:215-225.
17. Manolova Y, Manolov G, Apostolov P, Levan A (1979): The same marker chromosome, mar17p+, in four consecutive cases of multiple myeloma. Hereditas 90:307-310.
18. Solé F, Woessner S, Acín P, Pérez-Losada A, Florensa L, Besses C, Sans-Sabrafen J (1994): Burkitt's type translocation in multiple myeloma. Leuk Res 18:671-673.